Basic/Clinical Science Session
Great Debates in Hypertension
October 23, 2026 | 02:00 PM - 04:00 PM
Location: Mile High Ballroom 2, Convention Center
Session Description
Clarity is elusive as hypertension treatment for patients with CKD evolves amid new guidelines, devices, and clinical trial data. In this interactive debate session, internationally recognized experts tackle the most pressing controversies: how aggressively to lower blood pressure in CKD, whether and when to adopt renal denervation, and whether chronotherapy should be standard practice. Expect evidence-based arguments, spirited discussion, interactive polling, and practical pearls to inform your clinical approach.
Learning Objective(s)
- Describe evolving guidelines and evidence on optimal systolic blood pressure targets in CKD, balancing intensive and individualized approaches
- Assess the latest data on the efficacy and safety of renal denervation in hypertension management
- Critically discuss the evidence for and against routine bedtime dosing (chronotherapy) of antihypertensive agents in patients with CKD
Learning Pathway(s)
- Cardiovascular-Kidney-Metabolic (CKM) Health
Moderators
Presentations
- Renal Denervation Should Be Offered to Treat Mild Hypertension: Pro
02:00 PM - 02:20 PM
- Renal Denervation Should Be Offered to Treat Mild Hypertension: Con
02:20 PM - 02:40 PM
- Bedtime Dosing of Antihypertensive Medications Matters: Pro
02:40 PM - 03:00 PM
- Bedtime Dosing of Antihypertensive Medications Matters: Con
03:00 PM - 03:20 PM
- Systolic BP Targets Should Be Less Than 120 mm Hg in CKD: Pro
03:20 PM - 03:40 PM
- Systolic BP Targets Should Be Less Than 120 mm Hg in CKD: Con
03:40 PM - 04:00 PM